The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study

JAMA Intern Med. 2014 Oct;174(10):1568-76. doi: 10.1001/jamainternmed.2014.3889.

Abstract

Importance: Many Medicare beneficiaries undergo more intensive colonoscopy screening than recommended. Whether this is favorable for beneficiaries and efficient from a societal perspective is uncertain.

Objective: To determine whether more intensive colonoscopy screening than recommended is favorable for Medicare beneficiaries (ie, whether it results in a net health benefit) and whether it is efficient from a societal perspective (ie, whether the net health benefit justifies the additional resources required).

Design, setting, and participants: Microsimulation modeling study of 65-year-old Medicare beneficiaries at average risk for colorectal cancer (CRC) and with an average life expectancy who underwent a screening colonoscopy at 55 years with negative results.

Interventions: Colonoscopy screening as recommended by guidelines (ie, at 65 and 75 years) vs scenarios with a shorter screening interval (5 or 3 instead of 10 years) or in which screening was continued to 85 or 95 years.

Main outcomes and measures: Quality-adjusted life-years (QALYs) gained (measure of net health benefit); additional colonoscopies required per additional QALY gained and additional costs per additional QALY gained (measures of efficiency).

Results: Screening previously screened Medicare beneficiaries more intensively than recommended resulted in only small increases in CRC deaths prevented and life-years gained. In comparison, the increases in colonoscopies performed and colonoscopy-related complications experienced were large. As a result, all scenarios of more intensive screening than recommended resulted in a loss of QALYs, rather than a gain (ie, a net harm). The only exception was shortening the screening interval from 10 to 5 years, which resulted in 0.7 QALYs gained per 1000 beneficiaries. However, this scenario was inefficient because it required no less than 909 additional colonoscopies and an additional $711 000 per additional QALY gained. Results in previously unscreened beneficiaries were slightly less unfavorable, but conclusions were identical.

Conclusions and relevance: Screening Medicare beneficiaries more intensively than recommended is not only inefficient from a societal perspective; often it is also unfavorable for those being screened. This study provides evidence and a clear rationale for clinicians and policy makers to actively discourage this practice.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Colonoscopy* / adverse effects
  • Colonoscopy* / economics
  • Colonoscopy* / statistics & numerical data
  • Colorectal Neoplasms / prevention & control*
  • Early Detection of Cancer / adverse effects
  • Early Detection of Cancer / economics
  • Early Detection of Cancer / methods*
  • Early Detection of Cancer / statistics & numerical data*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Male
  • Medicare
  • Quality-Adjusted Life Years*
  • United States / epidemiology
  • Unnecessary Procedures* / adverse effects
  • Unnecessary Procedures* / economics
  • Unnecessary Procedures* / statistics & numerical data